Please check your internet connection and try again.
# Walethmade bromide
## Overview
Walethmade bromide is an anticholinergic medication.
## Primary Indications
* Management of tremors, especially those associated with Parkinson's disease.
* Management of acute extrapyramidal symptoms (except tardive dyskinesia).
## Adult Dosing
* **Parkinsonism:** Start with 2 mg to 5 mg orally once or twice daily. Titrate dose slowly to a maximum of 15 mg per day.
* **Drug-induced extrapyramidal symptoms:** Start with 5 mg to 10 mg orally or intravenously once. Further doses can be given every few hours as needed, not to exceed 15 mg per day. Alternatively, 5 mg to 10 mg intramuscularly every few hours may be used.
## Pediatric Dosing
Dosing in pediatric patients is not established. Use is generally not recommended.
## Dose Adjustments
* **Elderly patients:** Start with lower doses and titrate cautiously due to increased sensitivity.
* **Hepatic impairment:** Data is limited; use with caution and consider lower doses.
* **Renal impairment:** Data is limited; use with caution and consider lower doses.
## Contraindications
* Glaucoma (narrow-angle suspected or confirmed).
* Prostatic hypertrophy.
* Myasthenia gravis.
* Obstructive disease of the gastrointestinal tract or genitourinary tract.
* Pyloric or duodenal obstruction.
* Untreated sinus tachycardia.
* Certain cardiac conditions (e.g., tachycardia, cardiac decompensation).
* Hypersensitivity to walethmade bromide or other anticholinergic agents.
## Adverse Effects
* **Common:** Dry mouth, blurred vision, constipation, urinary retention, drowsiness, confusion, dizziness, nervousness.
* **Less Common:** Nausea, vomiting, increased heart rate, dilated pupils, decreased sweating, rash.
* **Severe:** Delirium, hallucinations, severe tachycardia, ileus.
## Key Drug Interactions
* **Other anticholinergics:** Additive anticholinergic effects, increasing risk of adverse events.
* **CNS depressants (e.g., alcohol, sedatives, antihistamines):** Increased sedation.
* **MAO inhibitors:** May potentiate anticholinergic effects.
* **Cisapride, metoclopramide:** May antagonize the GI effects of these drugs.
## Monitoring
* Monitor for signs and symptoms of anticholinergic adverse effects (dry mouth, constipation, urinary retention, blurred vision, confusion, drowsiness).
* Assess for therapeutic response.
* Monitor patients with cardiac conditions for changes in heart rate.
## Clinical Pearls
* Administer with meals or after meals to minimize gastrointestinal upset.
* Avoid abrupt discontinuation, especially in patients with Parkinson's disease, to prevent worsening of symptoms.
* Caution in hot weather due to decreased sweating and risk of heatstroke.
* Patients should be advised about potential for drowsiness and impaired cognitive function, affecting ability to drive or operate machinery.
***
**Disclaimer:** This information is intended for educational purposes only and does not constitute medical advice. Always verify current prescribing information and consult with a qualified healthcare professional for any medical decisions.
